Evidence map›Paper›PMID 25618850›Full record

ArticleNucleic acids research2015

A basal level of DNA damage and telomere deprotection increases the sensitivity of cancer cells to G-quadruplex interactive compounds.

Erica Salvati, Angela Rizzo, Sara Iachettini, Pasquale Zizza, Chiara Cingolani, Carmen D'Angelo, Manuela Porru, Chiara Mondello, Aurora Aiello, Antonella Farsetti and 3 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Telomere Targeting Approaches in Cancer: Beyond Length Maintenance.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Fundamentals of G-quadruplex biology.Annual reports in medicinal chemistry · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erica SalvatiExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Angela RizzoExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Sara IachettiniExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Pasquale ZizzaExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Chiara CingolaniExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Carmen D'AngeloExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Manuela PorruExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Chiara MondelloIstituto di Genetica Molecolare, National Research Council (CNR), Pavia, Italy.
Aurora AielloInstitute of Cell Biology and Neurobiology (IBCN), CNR Rome, Italy Department of Experimental Oncology, Regina Elena National Cancer Institute, Rome, Italy.
Antonella FarsettiInstitute of Cell Biology and Neurobiology (IBCN), CNR Rome, Italy Department of Experimental Oncology, Regina Elena National Cancer Institute, Rome, Italy.
Eric GilsonInstitute for Research on Cancer and Aging, Nice (IRCAN), CNRS UMR7284/INSERM U1081, University of Nice, Nice, France Department of Medical Genetics, Archet 2 Hospital, CHU of Nice, Nice, France.
Carlo LeonettiExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.
Annamaria BiroccioExperimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy biroccio@ifo.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, with the aim of obtaining insight into the intriguing selectivity of G-quadruplex (G4) ligands toward cancer compared to normal cells, a genetically controlled system of progressive transformation in human BJ fibroblasts was analyzed. Among the different comparative evaluations, we found a progressive increase of DNA damage response (DDR) markers throughout the genome from normal toward immortalized and transformed cells. More interestingly, sensitivity to G4 ligands strongly correlated with the presence of a basal level of DNA damage, including at the telomeres, where the chromosome ends were exposed to the DDR without concurrent induction of DNA repair activity, as revealed by the lack of 53BP1 recruitment and telomere aberrations. The link between telomere uncapping and the response to G4 stabilization was directly assessed by showing that a partial TRF2 depletion, causing a basal level of telomere localized DDR, rendered telomerized fibroblasts prone to G4-induced telomere damage and anti-proliferative defects. Taken together these data strongly indicate that the presence of a basal level of telomere-associated DDR is a determinant of susceptibility to G4 stabilization.

Indexed as

DNA DamageTelomereBlotting, WesternChromatin ImmunoprecipitationG-QuadruplexesHumansIn Situ Hybridization, FluorescenceNeoplasmsTumor Cells, Cultured

Identifiers

PMID25618850
PMCPMC4330372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.